ENTITY

InSilico Medicine Cayman TopCo (ISM HK)

3
Analysis
Health CareHong Kong

bearishQuantumPharm
04 Jun 2024 08:55

Pre-IPO QuantumPharm (PHIP Updates) - Some Points Worth the Attention

QuantumPharm's business model struggle to scale revenue solely through service fees. Profitability is a pain point for AI pharmaceutical companies....

Logo
388 Views
Share
bearishQuantumPharm
04 Jan 2024 08:55

Pre-IPO QuantumPharm - Good Stories May Not Be Backed up by Performance

It's hard for QuantumPharm to general large revenue scale in a short time due to the weakness in  business model. So, high valuation is...

Logo
779 Views
Share
13 Jul 2023 08:55

Pre-IPO InSilico Medicine - AI Pharmaceutical Is Immature; Valuation Expansion Relies on Imagination

AI can help with the efficiency problem, but it cannot subvert the basic outline of drug R&D process, which is very difficult, as at critical...

Logo
445 Views
Share
No more insights
x